AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • September 10th, 2014 • Silenseed Ltd. • Pharmaceutical preparations
This amendment (the “Amendment”) to the Agreement dated February 23, 2009 (the “Agreement”) is entered into by and between Hadasit Medical Research Services and Development Limited, (hereinafter: “Institution”), Prof. Eithan Galun (the “Consultant”), and Silenseed Ltd., a corporation organized under the laws of Israel, with its registered office located at the Goldyne Savad Institute of Gene Therapy, Hadassah Medical Center, Jerusalem 91120 Israel (hereinafter: “Company”) is made and effective as of March 12, 2012.
Hadasit Medical Research Services & Development Ltd, Jerusalem BioPark, Hadassah Ein Kerem. Jerusalem 91120, Israel Re: Agreement for the Rendering of Services EnvironmentSilenseed Ltd. • June 13th, 2014 • Pharmaceutical preparations
New Company’s Personnel introduced to the Environment will be subjected to the security procedures of the Hadassah. For the avoidance of doubt, usage of the space in the Environment is as described in Exhibit A attached hereto. Upon termination of employment of a Company employee for whatever reason, the Environment space made available to be used by another/new Company employee requires the approval of Prof. Eithan Galun, which approval shall not be unreasonably withheld. For the avoidance of doubt, the right of usage of such space of the Environment is not automatically granted to the Company, but approval shall not be unreasonably withheld.
CONSULTING AGREEMENTConsulting Agreement • September 10th, 2014 • Silenseed Ltd. • Pharmaceutical preparations
This Agreement is entered into as of February 23, 2009 with full force and effect as of June 10, 2008 (the "Effective Date") by and between HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LIMITED, a company duly incorporated under the laws of Israel, of P.O. Box 12000, Jerusalem 91120, (hereinafter: "Hadasit"), Prof Eithan Galun (the "Consultant"), and SILENSEED Ltd., a corporation organized under the laws of Israel, with its registered office located at the Goldyne Savad Institute of Gene Therapy, Hadassah Medical Center, Jerusalem 91120 Israel (hereinafter: "Company").
